Case Report: Primary hepatic neuroendocrine tumor: two cases report with literature review

Background & AimsPrimary hepatic neuroendocrine tumors (PHNETs) are rare malignant liver tumors that present diagnostic challenges owing to their rarity and absence of specific clinical features. This study aimed to investigate the characteristics of this rare liver tumor to enhance our unde...

Full description

Bibliographic Details
Main Authors: Yongsheng Tang, Xianyu Chen, Xu Lu, Zenan Yuan, Yang Yang, Chunhui Qiu, Hua Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1225583/full
_version_ 1797754567305199616
author Yongsheng Tang
Xianyu Chen
Xu Lu
Zenan Yuan
Yang Yang
Chunhui Qiu
Hua Li
author_facet Yongsheng Tang
Xianyu Chen
Xu Lu
Zenan Yuan
Yang Yang
Chunhui Qiu
Hua Li
author_sort Yongsheng Tang
collection DOAJ
description Background & AimsPrimary hepatic neuroendocrine tumors (PHNETs) are rare malignant liver tumors that present diagnostic challenges owing to their rarity and absence of specific clinical features. This study aimed to investigate the characteristics of this rare liver tumor to enhance our understanding of the disease, improve diagnostic accuracy, and explore standardized diagnostic and treatment approaches.Case descriptionDuring physical examination, two elderly women, aged 64 and 74 years, were found to have liver masses. 18F-FDG Positron Emission Tomography-Computed Tomography (18F-FDG PET-CT) and Ga68-DOTATATE PET-CT scans of both individuals revealed multiple liver masses that were initially suspected to be hepatic neuroendocrine tumors. Subsequent puncture pathology confirmed the diagnosis of neuroendocrine tumors. Furthermore, in Case 1, the tumor was also detected by 18F-FDG PET-CT in the lung, suggesting a metastatic tumor, in conjunction with liver immunohistochemistry and imaging findings. Laboratory tests revealed no significant abnormalities in liver function or autoimmune liver disease indicators, and there was no evidence of viral hepatitis infection. However, partial hepatectomy was not indicated for cases with distant metastasis or multiple space-occupying lesions. Individualized treatment approaches have been developed for such situations. A large portion of the tumor underwent Transarterial Embolization (TAE), and targeted combination chemotherapy or endocrine therapy was administered based on the pathological results. During regular follow-ups a 13 and 12 months, the tumor remained stable. The patients’ quality of life was good, and their psychological well-being was healthy. They led active lifestyles, demonstrated a thorough understanding of their disease and its progression, and actively cooperated during the follow-up process.ConclusionOur findings suggest that a combination of serological, radiological, and immunohistochemical examinations can aid in the diagnosis of PHNET. In addition, we determined that TAE combined with drug therapy could be an effective method for controlling PHNET progression. Regular postoperative follow-ups are important for monitoring the prognosis and tumor progression status of patients with PHNET.
first_indexed 2024-03-12T17:35:17Z
format Article
id doaj.art-23ebcc5d06ba4ad8b7cf2fd71e4a6d0a
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-03-12T17:35:17Z
publishDate 2023-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-23ebcc5d06ba4ad8b7cf2fd71e4a6d0a2023-08-04T11:51:00ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-08-011310.3389/fonc.2023.12255831225583Case Report: Primary hepatic neuroendocrine tumor: two cases report with literature reviewYongsheng Tang0Xianyu Chen1Xu Lu2Zenan Yuan3Yang Yang4Chunhui Qiu5Hua Li6Department of Hepatic Surgery, Liver Transplantation Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaDepartment of Hepatobiliary Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaDepartment of Hepatic Surgery, Liver Transplantation Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaDepartment of Hepatic Surgery, Liver Transplantation Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaDepartment of Hepatic Surgery, Liver Transplantation Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaDepartment of Hepatic Surgery, Liver Transplantation Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaDepartment of Hepatic Surgery, Liver Transplantation Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaBackground & AimsPrimary hepatic neuroendocrine tumors (PHNETs) are rare malignant liver tumors that present diagnostic challenges owing to their rarity and absence of specific clinical features. This study aimed to investigate the characteristics of this rare liver tumor to enhance our understanding of the disease, improve diagnostic accuracy, and explore standardized diagnostic and treatment approaches.Case descriptionDuring physical examination, two elderly women, aged 64 and 74 years, were found to have liver masses. 18F-FDG Positron Emission Tomography-Computed Tomography (18F-FDG PET-CT) and Ga68-DOTATATE PET-CT scans of both individuals revealed multiple liver masses that were initially suspected to be hepatic neuroendocrine tumors. Subsequent puncture pathology confirmed the diagnosis of neuroendocrine tumors. Furthermore, in Case 1, the tumor was also detected by 18F-FDG PET-CT in the lung, suggesting a metastatic tumor, in conjunction with liver immunohistochemistry and imaging findings. Laboratory tests revealed no significant abnormalities in liver function or autoimmune liver disease indicators, and there was no evidence of viral hepatitis infection. However, partial hepatectomy was not indicated for cases with distant metastasis or multiple space-occupying lesions. Individualized treatment approaches have been developed for such situations. A large portion of the tumor underwent Transarterial Embolization (TAE), and targeted combination chemotherapy or endocrine therapy was administered based on the pathological results. During regular follow-ups a 13 and 12 months, the tumor remained stable. The patients’ quality of life was good, and their psychological well-being was healthy. They led active lifestyles, demonstrated a thorough understanding of their disease and its progression, and actively cooperated during the follow-up process.ConclusionOur findings suggest that a combination of serological, radiological, and immunohistochemical examinations can aid in the diagnosis of PHNET. In addition, we determined that TAE combined with drug therapy could be an effective method for controlling PHNET progression. Regular postoperative follow-ups are important for monitoring the prognosis and tumor progression status of patients with PHNET.https://www.frontiersin.org/articles/10.3389/fonc.2023.1225583/fullTAEimmunohistochemistryprimary hepatic neuroendocrine tumors (PHNETs)PET-CTliver metastasisneuroendocrine tumor
spellingShingle Yongsheng Tang
Xianyu Chen
Xu Lu
Zenan Yuan
Yang Yang
Chunhui Qiu
Hua Li
Case Report: Primary hepatic neuroendocrine tumor: two cases report with literature review
Frontiers in Oncology
TAE
immunohistochemistry
primary hepatic neuroendocrine tumors (PHNETs)
PET-CT
liver metastasis
neuroendocrine tumor
title Case Report: Primary hepatic neuroendocrine tumor: two cases report with literature review
title_full Case Report: Primary hepatic neuroendocrine tumor: two cases report with literature review
title_fullStr Case Report: Primary hepatic neuroendocrine tumor: two cases report with literature review
title_full_unstemmed Case Report: Primary hepatic neuroendocrine tumor: two cases report with literature review
title_short Case Report: Primary hepatic neuroendocrine tumor: two cases report with literature review
title_sort case report primary hepatic neuroendocrine tumor two cases report with literature review
topic TAE
immunohistochemistry
primary hepatic neuroendocrine tumors (PHNETs)
PET-CT
liver metastasis
neuroendocrine tumor
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1225583/full
work_keys_str_mv AT yongshengtang casereportprimaryhepaticneuroendocrinetumortwocasesreportwithliteraturereview
AT xianyuchen casereportprimaryhepaticneuroendocrinetumortwocasesreportwithliteraturereview
AT xulu casereportprimaryhepaticneuroendocrinetumortwocasesreportwithliteraturereview
AT zenanyuan casereportprimaryhepaticneuroendocrinetumortwocasesreportwithliteraturereview
AT yangyang casereportprimaryhepaticneuroendocrinetumortwocasesreportwithliteraturereview
AT chunhuiqiu casereportprimaryhepaticneuroendocrinetumortwocasesreportwithliteraturereview
AT huali casereportprimaryhepaticneuroendocrinetumortwocasesreportwithliteraturereview